Rasopathy Disorders

Rasopathy Disorders News

• Researchers find link between mutations in TRAF7 gene and multisystem disorder 28 Jun 2018 17:00 News-Medical.net June 28, 2018 A group of seven patients presenting with a similar disorder of unknown origin now know of a possible genetic root of their condition. A team of researchers sequenced all the protein-coding genes in the patients' genomes and identified …
• Mutations in gene TRAF7 are associated with a multisystem disorder 28 Jun 2018 16:08 Medical Xpress A group of seven patients presenting with a similar disorder of unknown origin now know of a possible genetic root of their condition. A team of researchers sequenced all the protein-coding genes in the patients' genomes and identified four different …
• Onconova Therapeutics' (ONTX) CEO Ramesh Kumar on Q4 2017 Results - Earnings Call Transcript 09 Mar 2018 01:19 Seeking Alpha Start Time: 09:00 January 1, 0000 9:30 AM ET Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q4 2017 Earnings Conference Call March 08, 2018, 09:00 AM ET Executives Ramesh Kumar - CEO Mark Guerin - CFO Analysts Joe Pantginis - H.C. Wainwright Yale Jen - Laidlaw …
• International symposium on developments in neurofibromatoses, rasopathies to be held at Kochi from Nov 27─29 25 Nov 2017 06:22 Pharmabiz.com An international symposium on new developments in neurofibromatoses and rasopathies will be held from 27th  to 29th November 2017 at Crowne Plaza, Kochi (Cochin), Kerala, South India, which will deliberate on their management, diagnosis, current and …
• Onconova Therapeutics' (ONTX) CEO Ramesh Kumar on Q3 2017 Results - Earnings Call Transcript 09 Nov 2017 22:08 Seeking Alpha Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q3 2017 Earnings Conference Call November 9, 2017 09:00 AM EST Executives Ramesh Kumar - CEO Mark Guerin - CFO Analysts Jason McCarthy - Maxim Group Joe Pantginis - H.C. Wainwright Operator Good morning, and …
• Your Daily Pharma Scoop: MannKind Is A Trade Not An Investment; AstraZeneca's Imfinzi 10 Oct 2017 16:55 Seeking Alpha This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of Top Seeking Alpha Coverage: MannKind …
• BioNJ's Patient Advocacy Summit: Educate. Engage. Empower. 06 Sep 2017 19:35 PharmiWeb.com BioNJ Posted on: 06 Sep 17 BioNJ's 2nd Annual Patient Advocacy Summit is slated for Wednesday, November 8, at Celgene Corporation, Summit, NJ. The full-day event will bring together New Jersey's patient advocacy community with industry and …
• Benefit Planned For Acadiana Girl Battling Genetic Condition 31 May 2017 21:47 KPEL Subscribe to News Talk 96.5 KPEL on We have a ton of people come in and out of the KPEL studio doors, but this little girl was different. Little Amelie is battling CFC or Cardiofaciocutaneous. It took several doctors 11 months to figure out why little …
• Onconova Therapeutics' (ONTX) CEO Ramesh Kumar on Q1 2017 Results - Earnings Call Transcript 15 May 2017 20:20 Seeking Alpha Onconova Therapeutics (NASDAQ:ONTX) Q1 2017 Earnings Conference Call May 15, 2017 09:00 a.m. ET Executives Ramesh Kumar - CEO Mark Guerin - CFO Lisa Sher - IR Analysts Jason McCarthy - Maxim Group Yale Jen - Laidlaw & Company Kumaraguru Raja - Noble …
• Onconova Therapeutics, Inc. Reports Recent Business Highlights and First Quarter 2017 Financial Results 15 May 2017 12:41 GlobeNewswire NEWTOWN, Pa., May 15, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on …